Saiko Kurosawa

Summary

Affiliation: National Cancer Center
Country: Japan

Publications

  1. doi request reprint Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction
    Saiko Kurosawa
    Department of Hematology, Tokyo Metropolitan Bokutoh General Hospital, Tokyo, Japan
    Jpn J Clin Oncol 39:682-5. 2009
  2. doi request reprint Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha
    Saiko Kurosawa
    Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Electronic address
    Biol Blood Marrow Transplant 22:1125-32. 2016
  3. pmc Prognosis of patients with core binding factor acute myeloid leukemia after first relapse
    Saiko Kurosawa
    Haematologica 98:1525-31. 2013
  4. pmc Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission
    Masamitsu Yanada
    1Department of Hematology, Fujita Health University, Aichi, Japan
    Haematologica 97:915-8. 2012
  5. doi request reprint Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation
    Saiko Kurosawa
    Department of Stem Cell Transplantation, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Am J Hematol 84:815-20. 2009
  6. doi request reprint A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
    Saiko Kurosawa
    Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
    Blood 117:2113-20. 2011
  7. ncbi request reprint High non-relapse mortality and low relapse incidence in gender-mismatched allogeneic hematopoietic stem cell transplantation from a parous female donor with a male child
    Akihito Shinohara
    a Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
    Leuk Lymphoma . 2016
  8. pmc Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
    Saiko Kurosawa
    Stem Cell Transplantation Division, National Cancer Center Hospital, Chuo Ku, Tokyo 104 0045, Japan
    Haematologica 95:1857-64. 2010
  9. doi request reprint Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation
    Takashi Tanaka
    Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
    Biol Blood Marrow Transplant 22:919-24. 2016
  10. doi request reprint Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission
    Saiko Kurosawa
    Stem Cell Transplantation Division, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Biol Blood Marrow Transplant 17:401-11. 2011

Collaborators

Detail Information

Publications20

  1. doi request reprint Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction
    Saiko Kurosawa
    Department of Hematology, Tokyo Metropolitan Bokutoh General Hospital, Tokyo, Japan
    Jpn J Clin Oncol 39:682-5. 2009
    ..This case may give suggestions about diagnosing and preventing the progression of complications from this disease entity...
  2. doi request reprint Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha
    Saiko Kurosawa
    Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Electronic address
    Biol Blood Marrow Transplant 22:1125-32. 2016
    ..A prospective study is warranted to determine the value of allo-HCT, especially in FLT3-ITD-negative patients. ..
  3. pmc Prognosis of patients with core binding factor acute myeloid leukemia after first relapse
    Saiko Kurosawa
    Haematologica 98:1525-31. 2013
    ..These findings may help to guide therapeutic decisions after first relapse. ..
  4. pmc Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission
    Masamitsu Yanada
    1Department of Hematology, Fujita Health University, Aichi, Japan
    Haematologica 97:915-8. 2012
    ....
  5. doi request reprint Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation
    Saiko Kurosawa
    Department of Stem Cell Transplantation, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Am J Hematol 84:815-20. 2009
    ..However, effective measures to prevent disease progression after a second HCT clearly need to be developed...
  6. doi request reprint A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
    Saiko Kurosawa
    Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
    Blood 117:2113-20. 2011
    ..Our results showed that older patients with a related donor and younger patients with unfavorable cytogenetics benefited the most from allo-HCT in CR1...
  7. ncbi request reprint High non-relapse mortality and low relapse incidence in gender-mismatched allogeneic hematopoietic stem cell transplantation from a parous female donor with a male child
    Akihito Shinohara
    a Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
    Leuk Lymphoma . 2016
    ..08-3.42, p = .03), a reduced risk of RI (HR 0.42, 95% CI 0.18-0.96, p = .04), resulting in no significant difference regarding overall survival. Male child of FD is suggested to influence NRM and RI in gender-mismatched HSCT...
  8. pmc Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
    Saiko Kurosawa
    Stem Cell Transplantation Division, National Cancer Center Hospital, Chuo Ku, Tokyo 104 0045, Japan
    Haematologica 95:1857-64. 2010
    ..We, therefore, retrospectively analyzed data from patients with acute myeloid leukemia who had achieved first complete remission to assess their prognosis after first relapse...
  9. doi request reprint Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation
    Takashi Tanaka
    Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
    Biol Blood Marrow Transplant 22:919-24. 2016
    ..Eltrombopag is a promising treatment for both PIT and SFPR after allogeneic HCT. The number of megakaryocytes in bone marrow before eltrombopag treatment may predict the response to eltrombopag. ..
  10. doi request reprint Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission
    Saiko Kurosawa
    Stem Cell Transplantation Division, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Biol Blood Marrow Transplant 17:401-11. 2011
    ..The introduction of appropriate treatment strategies that include allo-HCT may improve the outcome in elderly patients with AML in CR1...
  11. doi request reprint Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases
    Shigeo Fuji
    Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    Int J Hematol 98:608-14. 2013
    ..The beneficial effect of low-dose ATG-F should be assessed in a prospective clinical trial...
  12. doi request reprint Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography
    Ryosuke Ueda
    Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    Int J Hematol 102:121-8. 2015
    ..None of the patients died of NV-GE. In conclusion, IC may be useful in the differential diagnosis of diarrhea after allogeneic HSCT, and could enable the appropriate adjustment of immunosuppressive drugs and prompt preventive measures...
  13. doi request reprint Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma
    Kohei Tada
    Department of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
    Am J Hematol 87:770-5. 2012
    ..These results suggest that allo-HCT may be a promising option for patients with not only advanced FL but also DLBCL associated with FL...
  14. doi request reprint Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation
    Kodai Kuriyama
    Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5 1 1, Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    Int J Hematol 103:453-60. 2016
    ..The use of low-dose ATG-T in patients who received uHSCT was associated with a superior GRFS, reflecting the reduced incidence of severe/persistent GVHD without compromising overall survival...
  15. doi request reprint Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission
    Kensuke Usuki
    Division of Hematology, NTT Kanto Medical Center, Tokyo, Japan
    Clin Lymphoma Myeloma Leuk 12:444-51. 2012
    ..Using a database of 2518 adult patients with AML in CR1, we conducted a 5-month landmark analysis and found that auto-HCT improves 3-year RFS but not OS compared with chemotherapy...
  16. doi request reprint Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients
    Nobuhiro Hiramoto
    Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
    Eur J Haematol 92:137-46. 2014
    ..These findings suggest that the graft-versus-leukemia effect may be more beneficial in high-risk patients who do not receive intensive preparative regimens. ..
  17. doi request reprint Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease
    Yayoi Matsumura-Kimoto
    Department of Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Biol Blood Marrow Transplant 22:1102-7. 2016
    ..14; P = .02). Strategies to reduce the risk of infectious complications are needed, particularly for patients who have risk factors and those who receive high cumulative steroid doses. ..
  18. pmc Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations
    Takeshi Ryotokuji
    Department of Hematology, Nippon Medical School, Tokyo, Japan
    Haematologica 101:1074-81. 2016
    ..0254). Our study establishes that DNA-methylation regulatory gene mutation is an important unfavorable prognostic factor in acute myeloid leukemia. ..
  19. ncbi request reprint Clinical and epidemiological features of Clostridium perfringens bacteremia: a review of 18 cases over 8 year-period in a tertiary care center in metropolitan Tokyo area in Japan
    Hiroshi Fujita
    Department of Transfusion Medicine, Tokyo Metropolitan Bokutoh General Hospital, Tokyo, Japan
    Intern Med 49:2433-7. 2010
    ..Therefore, we retrospectively examined the clinical features of patients with systemic inflammatory response syndrome (SIRS) from whose blood cultures Clostridium perfringens was isolated...
  20. doi request reprint Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients
    Hiroki Yokoyama
    Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
    Int J Hematol 92:334-41. 2010
    ..The present findings warrant future prospective studies...